Lexicon Pharmaceuticals Inc (LXRX)
1.545
-0.06
(-3.44%)
USD |
NASDAQ |
Apr 25, 16:00
1.55
0.00 (0.00%)
After-Hours: 20:00
Lexicon Pharmaceuticals Free Cash Flow: -162.37M for Dec. 31, 2023
Free Cash Flow Chart
Historical Free Cash Flow Data
| Date | Value |
|---|---|
| December 31, 2023 | -162.37M |
| September 30, 2023 | -134.63M |
| June 30, 2023 | -112.38M |
| March 31, 2023 | -98.54M |
| December 31, 2022 | -90.18M |
| September 30, 2022 | -90.21M |
| June 30, 2022 | -88.13M |
| March 31, 2022 | -86.54M |
| December 31, 2021 | -88.24M |
| September 30, 2021 | -99.68M |
| June 30, 2021 | -122.73M |
| March 31, 2021 | -146.20M |
| December 31, 2020 | -143.06M |
| September 30, 2020 | -133.13M |
| June 30, 2020 | 97.98M |
| March 31, 2020 | 117.37M |
| December 31, 2019 | 113.74M |
| September 30, 2019 | 110.94M |
| June 30, 2019 | -101.94M |
| March 31, 2019 | -127.58M |
| December 31, 2018 | -148.70M |
| September 30, 2018 | -155.25M |
| June 30, 2018 | -167.09M |
| March 31, 2018 | -146.85M |
| December 31, 2017 | -185.62M |
| Date | Value |
|---|---|
| September 30, 2017 | -200.85M |
| June 30, 2017 | -202.06M |
| March 31, 2017 | -217.65M |
| December 31, 2016 | -175.86M |
| September 30, 2016 | 138.76M |
| June 30, 2016 | 148.32M |
| March 31, 2016 | 163.57M |
| December 31, 2015 | 183.87M |
| September 30, 2015 | -86.30M |
| June 30, 2015 | -81.83M |
| March 31, 2015 | -68.86M |
| December 31, 2014 | -75.70M |
| September 30, 2014 | -93.17M |
| June 30, 2014 | -96.17M |
| March 31, 2014 | -98.04M |
| December 31, 2013 | -92.80M |
| September 30, 2013 | -91.39M |
| June 30, 2013 | -92.30M |
| March 31, 2013 | -92.83M |
| December 31, 2012 | -94.95M |
| September 30, 2012 | -97.11M |
| June 30, 2012 | -92.39M |
| March 31, 2012 | -94.33M |
| December 31, 2011 | -89.14M |
| September 30, 2011 | -86.11M |
Free Cash Flow Range, Past 5 Years
-162.37M
Minimum
Dec 2023
117.37M
Maximum
Mar 2020
-66.21M
Average
-98.54M
Median
Mar 2023
Free Cash Flow Benchmarks
| Novavax Inc | -772.77M |
| AIM ImmunoTech Inc | -21.85M |
| Perspective Therapeutics Inc | -37.98M |
| Protalix BioTherapeutics Inc | -2.467M |
| Armata Pharmaceuticals Inc | -55.57M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -50.55M |
| Cash from Investing (Quarterly) | 51.90M |
| Cash from Financing (Quarterly) | -0.001M |
| Free Cash Flow Per Share (Quarterly) | -0.2062 |
| Free Cash Flow to Equity (Quarterly) | -50.79M |
| Free Cash Flow Yield | -47.56% |